Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,334 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Plasma lipid peroxidation biomarkers for early and non-invasive Alzheimer Disease detection.
Peña-Bautista C, Vigor C, Galano JM, Oger C, Durand T, Ferrer I, Cuevas A, López-Cuevas R, Baquero M, López-Nogueroles M, Vento M, Hervás D, García-Blanco A, Cháfer-Pericás C. Peña-Bautista C, et al. Among authors: ferrer i. Free Radic Biol Med. 2018 Aug 20;124:388-394. doi: 10.1016/j.freeradbiomed.2018.06.038. Epub 2018 Jun 30. Free Radic Biol Med. 2018. PMID: 29969716
Plasma isoprostanoids assessment as Alzheimer's disease progression biomarkers.
Peña-Bautista C, Álvarez L, Baquero M, Ferrer I, García L, Hervás-Marín D, Cháfer-Pericás C. Peña-Bautista C, et al. Among authors: ferrer i. J Neurochem. 2021 Jun;157(6):2187-2194. doi: 10.1111/jnc.15183. Epub 2020 Sep 30. J Neurochem. 2021. PMID: 32918484 Free article. Clinical Trial.
Lipid Peroxidation Assessment in Preclinical Alzheimer Disease Diagnosis.
Peña-Bautista C, Álvarez-Sánchez L, Ferrer I, López-Nogueroles M, Cañada-Martínez AJ, Oger C, Galano JM, Durand T, Baquero M, Cháfer-Pericás C. Peña-Bautista C, et al. Among authors: ferrer i. Antioxidants (Basel). 2021 Jun 29;10(7):1043. doi: 10.3390/antiox10071043. Antioxidants (Basel). 2021. PMID: 34209667 Free PMC article.
miR-519a-3p, found to regulate cellular prion protein during Alzheimer's disease pathogenesis, as a biomarker of asymptomatic stages.
Jácome D, Cotrufo T, Andrés-Benito P, Lidón L, Martí E, Ferrer I, Del Río JA, Gavín R. Jácome D, et al. Among authors: ferrer i. Biochim Biophys Acta Mol Basis Dis. 2024 Apr 21;1870(5):167187. doi: 10.1016/j.bbadis.2024.167187. Online ahead of print. Biochim Biophys Acta Mol Basis Dis. 2024. PMID: 38653354 Free article.
1,334 results